Skip to main content
SpringerLink
Log in

Percutaneous coronary intervention: balloons, stents and scaffolds

  • Review
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

In this review, major achievements in the field of percutaneous coronary interventions are delineated with particular focus on Germany’s contribution. The review deals with important developments, including the first heart catheterization and coronary angiography, first coronary balloon angioplasty and refinement of the technique, coronary stenting and optimization of adjunctive antithrombotic treatment, drug-eluting stents and balloons, as well as bioresorbable polymeric and metallic drug-eluting scaffolds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. King SB 3rd (1998) The development of interventional cardiology. J Am Coll Cardiol 31:64b–88b

    Article  PubMed  Google Scholar 

  2. Wierny L, Plass R, Porstmann W (1974) Long-term results in 100 consecutive patients treated by transluminal angioplasty. Radiology 112:543–548

    Article  PubMed  CAS  Google Scholar 

  3. Kaltenbach M (2002) Evolution of interventional cardiology in Germany. J Interv Cardiol 15:33–39

    Article  PubMed  Google Scholar 

  4. Simpson JB, Baim DS, Robert EW, Harrison DC (1982) A new catheter system for coronary angioplasty. Am J Cardiol 49:1216–1222

    Article  PubMed  CAS  Google Scholar 

  5. Kaltenbach M (1984) The long wire technique—a new technique for steerable balloon catheter dilatation of coronary artery stenoses. Eur Heart J 5:1004–1009

    Article  PubMed  CAS  Google Scholar 

  6. Bonzel T, Wollschläger H, Just H (1986) A new catheter system for the mechanical dilatation of coronary stenoses with exchangeable intracoronary catheters, fast flow of the contrast agent and improved control. Biomed Tech 31:195–200

    Article  CAS  Google Scholar 

  7. Byrne RA, Stone GW, Ormiston J, Kastrati A (2017) Coronary balloon angioplasty, stents, and scaffolds. Lancet 390:781–792

    Article  PubMed  Google Scholar 

  8. Byrne RA, Joner M, Kastrati A (2015) Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014. Eur Heart J 36:3320–3331

    Google Scholar 

  9. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701–706

    Article  PubMed  CAS  Google Scholar 

  10. Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211–214

    Article  PubMed  CAS  Google Scholar 

  11. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G et al (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489–495

    Article  PubMed  CAS  Google Scholar 

  12. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I et al (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331:496–501

    Article  PubMed  CAS  Google Scholar 

  13. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M et al (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084–1089

    Article  PubMed  CAS  Google Scholar 

  14. Kastrati A, Dirschinger J, Boekstegers P, Elezi S, Schuhlen H, Pache J et al (2000) Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv 50:290–297

    Article  PubMed  CAS  Google Scholar 

  15. Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL et al (2011) Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 123:1400–1409

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Simon C, Palmaz JC, Sprague EA (2000) Influence of topography on endothelialization of stents: clues for new designs. J Long Term Effects Med Implants 10:143–151

    Article  CAS  Google Scholar 

  17. Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schuhlen H, Neumann FJ et al (2001) Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 103:2816–2821

    Article  PubMed  CAS  Google Scholar 

  18. Pache J, Kastrati A, Mehilli J, Schuhlen H, Dotzer F, Hausleiter J et al (2003) Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 41:1283–1288

    Article  PubMed  Google Scholar 

  19. Schulz S, Mehilli J, Schomig A, Kastrati A (2010) ISAR—a story of trials with impact on practice. Circ J 74:1771–1778

    Article  PubMed  CAS  Google Scholar 

  20. Palmaz JC, Benson A, Sprague EA (1999) Influence of surface topography on endothelialization of intravascular metallic material. J Vasc Interv Radiol 10:439–444

    Article  PubMed  CAS  Google Scholar 

  21. Nakayama Y, Nishi S, Ishibashi-Ueda H, Matsuda T (2000) Surface microarchitectural design in biomedical applications: in vivo analysis of tissue ingrowth in excimer laser-directed micropored scaffold for cardiovascular tissue engineering. J Biomed Mater Res 51:520–528

    Article  PubMed  CAS  Google Scholar 

  22. Dibra A, Kastrati A, Mehilli J, Pache J, von Oepen R, Dirschinger J et al (2005) Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial. Catheter Cardiovasc Interv 65:374–380

    Article  PubMed  Google Scholar 

  23. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780

    Article  PubMed  CAS  Google Scholar 

  24. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT et al (2004) One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 109:1942–1947

    Article  PubMed  CAS  Google Scholar 

  25. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202

    Article  PubMed  Google Scholar 

  26. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A et al (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370:937–948

    Article  PubMed  CAS  Google Scholar 

  27. Wessely R, Hausleiter J, Michaelis C, Jaschke B, Vogeser M, Milz S et al (2005) Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol 25:748–753

    Article  PubMed  CAS  Google Scholar 

  28. Hausleiter J, Kastrati A, Wessely R, Dibra A, Mehilli J, Schratzenstaller T et al (2005) Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating. Eur Heart J 26:1475–1481

    Article  PubMed  Google Scholar 

  29. Mehilli J, Byrne RA, Wieczorek A, Iijima R, Schulz S, Bruskina O et al (2008) Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. Eur Heart J 29:1975–1982

    Article  PubMed  CAS  Google Scholar 

  30. Desch S, Schloma D, Mobius-Winkler S, Erbs S, Gielen S, Linke A et al (2011) Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial. JACC Cardiovasc Interv 4:452–459

    Article  PubMed  Google Scholar 

  31. Steigerwald K, Merl S, Kastrati A, Wieczorek A, Vorpahl M, Mannhold R et al (2009) The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts. Biomaterials 30:632–637

    Article  PubMed  CAS  Google Scholar 

  32. Byrne RA, Kastrati A, Kufner S, Massberg S, Birkmeier KA, Laugwitz KL et al (2009) Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. Eur Heart J 30:2441–2449

    Article  PubMed  Google Scholar 

  33. Kufner S, Byrne RA, Valeskini M, Schulz S, Ibrahim T, Hoppmann P et al (2016) Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial. EuroIntervention 11:1372–1379

    Article  PubMed  Google Scholar 

  34. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A et al (2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 372:1163–1173

    Article  PubMed  CAS  Google Scholar 

  35. Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A et al (2011) Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet 378:1940–1948

    Article  PubMed  CAS  Google Scholar 

  36. Stefanini GG, Byrne RA, Serruys PW, de Waha A, Meier B, Massberg S et al (2012) Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J 33:1214–1222

    Article  PubMed  CAS  Google Scholar 

  37. Tardif JC, Cote G, Lesperance J, Bourassa M, Lambert J, Doucet S et al (1997) Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med 337:365–372

    Article  PubMed  CAS  Google Scholar 

  38. Massberg S, Byrne RA, Kastrati A, Schulz S, Pache J, Hausleiter J et al (2011) Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial. Circulation 124:624–632

    Article  PubMed  CAS  Google Scholar 

  39. Kufner S, Sorges J, Mehilli J, Cassese S, Repp J, Wiebe J et al (2016) Randomized trial of polymer-free sirolimus- and probucol-eluting stents versus durable polymer zotarolimus-eluting stents: 5-year results of the ISAR-TEST-5 Trial. JACC Cardiovasc Interv 9:784–792

    Article  PubMed  Google Scholar 

  40. Byrne RA, Serruys PW, Baumbach A, Escaned J, Fajadet J, James S et al (2015) Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. Eur Heart J 36:2608–2620

    Article  PubMed  Google Scholar 

  41. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M et al (1997) Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30:1428–1436

    Article  PubMed  CAS  Google Scholar 

  42. Kastrati A, Elezi S, Dirschinger J, Hadamitzky M, Neumann FJ, Schomig A (1999) Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 83:1617–1622

    Article  PubMed  CAS  Google Scholar 

  43. Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T et al (2014) Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 100:153–159

    Article  PubMed  Google Scholar 

  44. Cassese S, Byrne RA, Schulz S, Hoppman P, Kreutzer J, Feuchtenberger A et al (2015) Prognostic role of restenosis in 10,004 patients undergoing routine control angiography after coronary stenting. Eur Heart J 36:94–99

    Article  PubMed  Google Scholar 

  45. Scheller B, Speck U, Schmitt A, Bohm M, Nickenig G (2003) Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol 42:1415–1420

    Article  PubMed  CAS  Google Scholar 

  46. Scheller B, Speck U, Romeike B, Schmitt A, Sovak M, Bohm M et al (2003) Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J 24:1462–1467

    Article  PubMed  CAS  Google Scholar 

  47. Speck U, Scheller B, Abramjuk C, Grossmann S, Mahnkopf D, Simon O (2004) Inhibition of restenosis in stented porcine coronary arteries: uptake of paclitaxel from angiographic contrast media. Investig Radiol 39:182–186

    Article  CAS  Google Scholar 

  48. Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110:810–814

    Article  PubMed  CAS  Google Scholar 

  49. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355:2113–2124

    Article  PubMed  CAS  Google Scholar 

  50. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K et al (2013) Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 381:461–467

    Article  PubMed  CAS  Google Scholar 

  51. Alfonso F, Perez-Vizcayno MJ, Cardenas A, Garcia del B, Blanco A, Garcia-Touchard JR, Lopez-Minguez et al (2015) A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial. J Am Coll Cardiol 66:23–33

    Article  PubMed  CAS  Google Scholar 

  52. Siontis GC, Stefanini GG, Mavridis D, Siontis KC, Alfonso F, Perez-Vizcayno MJ et al (2015) Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet 386:655–664

    Article  PubMed  Google Scholar 

  53. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619

    Article  PubMed  Google Scholar 

  54. Kleber FX, Rittger H, Ludwig J, Schulz A, Mathey DG, Boxberger M et al (2016) Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clin Res Cardiol 105:613–621

    Article  CAS  Google Scholar 

  55. Adriaenssens T, Byrne R (2014) PREvention of late Stent Thrombosis by an Interdisciplinary Global European effort: PRESTIGE. Eur Heart J 35:2128–2129

    PubMed  Google Scholar 

  56. Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E et al (2017) Optical coherence tomography findings in patients with coronary stent thrombosis: a Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort). Circulation 136:1007–1021

    Article  PubMed  PubMed Central  Google Scholar 

  57. Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J et al (2015) Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet 387:537–544

    Google Scholar 

  58. Ali ZA, Serruys PW, Kimura T, Gao R, Ellis SG, Kereiakes DJ et al (2017) 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet 390:760–772

    Article  PubMed  CAS  Google Scholar 

  59. Kereiakes DJ, Ellis SG, Metzger C, Caputo RP, Rizik DG, Teirstein PS et al (2017) 3-Year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III Trial. J Am Coll Cardiol 70:2852–2862

    Article  PubMed  CAS  Google Scholar 

  60. Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrie D, Piek JJ et al (2016) Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 388:2479–2491

    Article  PubMed  CAS  Google Scholar 

  61. Wykrzykowska JJ, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, IJsselmuiden AJ et al (2017) Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med 376:2319–2328

    Article  PubMed  CAS  Google Scholar 

  62. Sanchez OD, Yahagi K, Byrne RA, Mori H, Zarpak R, Wittchow E et al (2015) Pathological aspects of bioresorbable stent implantation. EuroIntervention 11(Suppl V):V159–V165

    Google Scholar 

  63. Raber L, Brugaletta S, Yamaji K, O’Sullivan CJ, Otsuki S, Koppara T et al (2015) Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings. J Am Coll Cardiol 66:1901–1914

    Article  PubMed  CAS  Google Scholar 

  64. Fajadet J, Haude M, Joner M, Koolen J, Lee M, Tolg R et al (2016) Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016. EuroIntervention 12:828–833

    Article  PubMed  Google Scholar 

  65. Erbel R, Mario CD, Bartunek J, Bonnier J, de Bruyne B, Eberli FR et al (2007) Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 369:1869–1875

    Article  PubMed  CAS  Google Scholar 

  66. Haude M, Erbel R, Erne P, Verheye S, Degen H, Bose D et al (2013) Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. Lancet 381:836–844

    Article  PubMed  CAS  Google Scholar 

  67. Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C et al (2016) Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. Lancet 387:31–39

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Deutshes Herzzentrum München, Technische Universität München, Lazarettstr 36, 80636, Munich, Germany

    Roisin Colleran & Adnan Kastrati

  2. DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany

    Adnan Kastrati

Authors
  1. Roisin Colleran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adnan Kastrati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adnan Kastrati.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Colleran, R., Kastrati, A. Percutaneous coronary intervention: balloons, stents and scaffolds. Clin Res Cardiol 107 (Suppl 2), 55–63 (2018). https://doi.org/10.1007/s00392-018-1328-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-018-1328-x

Keywords

Search

Navigation